JAMES CARLY: Open Payments
NPI 1316240575 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$677 in 30 payments from 11 companies in 2025. Trend: 2023 $920 · 2024 $639 · 2025 $677
Food & beverage: $677
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 3 | $169 |
| ABBVIE INC. | 6 | $135 |
| Regeneron Healthcare Solutions, Inc. | 4 | $95 |
| Novartis Pharmaceuticals Corporation | 3 | $83 |
| Biofrontera Inc. | 3 | $58 |
| Organon LLC | 4 | $39 |
| LEO Pharma Inc. | 2 | $28 |
| STRATA Skin Sciences, Inc. | 2 | $23 |
| Arcutis Biotherapeutics, Inc. | 1 | $17 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $16 |
Products named: Bimzelx, SKYRIZI, DUPIXENT, AMELUZ, VTAMA, ADBRY, RINVOQ, XTRAC.
Industry payments across UT — which companies pay providers there.
